As regulatory and compliance burdens increase for many companies, the role of — and the need for the board to rely on — the in-house tax function in meeting the company’s regulatory and compliance obligations is increasing. There are many factors contributing to this change and varying views on when board reliance on in-house tax departments is appropriate. It’s also important for boards to determine if the in-house department has the necessary resources to fulfill its expanding responsibilities.
Read the complete article by clicking the link below.
Read the complete article by clicking the link below.
Author(s)
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…